Dall'Ara Francesca, Andreoli Laura, Piva Nicole, Piantoni Silvia, Franceschini Franco, Tincani Angela
Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia; and Rheumatology Chair, University of Pavia, Italy.
Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Italy.
Clin Exp Rheumatol. 2015 Mar-Apr;33(2):153-8. Epub 2015 Jan 29.
Patients with systemic lupus erythematosus (SLE) are prone to hypo-vitaminosis D because of their photosensitivity. Vitamin D (vit.D) has beneficial effects not only on bone metabolism but also on the function of the immune system. The relationship between SLE disease activity and vit.D status is controversial and little is known on the effects of current supplementation strategies given for osteoporosis in raising vit.D levels.
Vit.D levels were measured longitudinally in 50 SLE patients from Northern Italy at two time-points (winter and summer) during disease remission. Thirty patients were also evaluated during a flare. As controls, 170 healthy donors were enrolled. All the samples were analysed for 25-OH vit.D levels by a chemiluminescence assay (DiaSorin SpA, Italy).
SLE patients had lower vit.D levels than controls in the summer (median 29.4 vs. 39.2 ng/ml, p=0.005) but not in the winter (26.4 vs. 21.6 ng/ml). During wintertime, 36 SLE patients were supplemented with vit.D drops (n=24; 48%), vit.D+calcium tablets (n=12; 24%), while 14 (28%) received no supplementation. Patients on oral drops had significantly higher vit.D levels than patients on tablets. The median weekly dosage was higher for oral drops than for tablets (6250 vs. 4560 UI, p=0.009). Winter flares were associated with lower vit.D levels in comparison with remission during the same season for each patient (21.1 vs. 30 ng/ml).
Current strategies of vit.D supplementation seem to be not sufficient for reaching an optimal vit.D status in Italian SLE patients. Vit.D and calcium tablets were less effective, probably because of lower vit.D content and poorer compliance. Vit.D insufficiency detected in the wintertime can be either a predisposing factor for flare or the consequence of the flare itself in SLE patients.
系统性红斑狼疮(SLE)患者由于光敏性易患维生素D缺乏症。维生素D(vit.D)不仅对骨代谢有益,而且对免疫系统功能也有好处。SLE疾病活动与vit.D状态之间的关系存在争议,对于目前用于骨质疏松症的补充策略提高vit.D水平的效果知之甚少。
在疾病缓解期的两个时间点(冬季和夏季),对来自意大利北部的50例SLE患者的vit.D水平进行纵向测量。30例患者在病情发作期间也进行了评估。作为对照,纳入了170名健康捐献者。所有样本均通过化学发光法(DiaSorin SpA,意大利)分析25-OH vit.D水平。
SLE患者夏季的vit.D水平低于对照组(中位数29.4 vs. 39.2 ng/ml,p = 0.005),但冬季则不然(26.4 vs. 21.6 ng/ml)。在冬季,36例SLE患者补充了vit.D滴剂(n = 24;48%)、vit.D + 钙片(n = 12;24%),而14例(28%)未接受补充。服用滴剂的患者的vit.D水平显著高于服用片剂的患者。口服滴剂的每周中位剂量高于片剂(6250 vs. 4560 UI,p = 0.009)。与同一季节的缓解期相比,冬季病情发作与较低的vit.D水平相关(21.1 vs. 30 ng/ml)。
目前的vit.D补充策略似乎不足以使意大利SLE患者达到最佳的vit.D状态。vit.D和钙片效果较差,可能是因为vit.D含量较低且依从性较差。冬季检测到的vit.D不足可能是SLE患者病情发作的诱发因素或病情发作本身的后果。